Advertisement
Journal Home
Search for

Volume 153, Issue 3, Pages 379-384.e1 (September 2008)


View previous. 36 of 57 View next.

Hyperglycemia and Outcome in the Pediatric Intensive Care Unit

Genna W. Klein, MDa, Joanne M. Hojsak, MDb, James Schmeidler, PhDc, Robert Rapaport, MDaCorresponding Author Informationemail address

Received 17 August 2007; received in revised form 21 December 2007; accepted 2 April 2008. published online 27 May 2008.

Objective

To identify the frequency of hyperglycemia in children who are nondiabetic and critically ill and assess the independent effect of hyperglycemia on outcome.

Study design

Consecutive admissions to the pediatric intensive care unit (PICU) were reviewed. The Pediatric Risk of Mortality III score (PRISM) measured patient acuity. Because maximum glucose level in the first day of PICU admission (GLFD) >200mg/dL contributes to PRISM, 200 mg/dL was used to differentiate high glucose (HG) from normal glucose.

Results

Of 1550 patients, 221 (14.3%) had HG. GLFD correlated with PRISM (r = 0.39, P < .001). Without controlling for PRISM, the HG group had more mechanical ventilation days (MVD; P < .001), longer PICU length of stay (PLOS; P < .001) and lower percent survival (P < .001) than the normal glucose group. Controlling for PRISM in survivors, GLFD was not associated with PLOS (P = .75) or with MVD (P = .06). GLFD was not significantly associated with survival (P = .76). In nonsurvivors, GLFD was not associated with PLOS (P = .19) or MVD (P = .31).

Conclusion

When controlling for disease severity, hyperglycemia within 24 hours of PICU admission was not independently associated with increased mechanical ventilation time, length of stay, or mortality. Prospective evaluation of glycemic control in critically ill children is needed to elucidate its effects on outcome.

a Mount Sinai School of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, New York, NY

b Department of Pediatrics, Division of Pediatric Pulmonary and Critical Care Medicine, New York, NY

c Department of Psychiatry, New York, NY

Corresponding Author InformationReprint requests: Robert Rapaport, Mount Sinai School of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, Box 1616, One Gustave L. Levy Place, New York, NY 10029

 No conflicts of interest or sources of financial assistance to disclose.

PII: S0022-3476(08)00279-5

doi:10.1016/j.jpeds.2008.04.012


View previous. 36 of 57 View next.

Advertisement